Development of ureadepsipetides for drug-resistant infections

Ended Project Grant Awarded Last action

Award ID
R01AI141193
Recipient
Awarding agency
Obligated
$11,168,616

Award facts

Assistance listing
93.855 Allergy and Infectious Diseases Research
Completion date
Originally
Funding
  • $9,958,999.00 Federal
  • $1,209,617.00 Non-federal
Place of performance
Massachusetts, USA

Award details come from USAspending.gov.

Transactions

Action Federal Non-federal Date
Amendment $0 $0
Amendment $1,186,918 $0
Amendment $1,186,918 $0
Amendment $1,200,871 $0
Amendment $1,200,871 $0
Amendment $1,209,617 $0
Amendment Development of ureadepsipetides for drug-resistant infections - the goal of this project is to develop udep antibiotics, which cause bacterial cells to… $1,209,617 $1,209,617
Amendment $72,670 $0
Amendment $67,619 $0
Amendment $1,167,526 $0
Original award $1,456,372 $0
Show all 11

Quick answers

Who received award R01AI141193?

R01AI141193 was awarded to Arietis Corporation by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on December 17, 2018.

How much is award R01AI141193 worth?

$11,168,616 has been obligated on R01AI141193: $9,958,999 in federal funding and $1,209,617 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award